Shinichi Toyooka
Okayama University · 1,014 works · 27,149 citations · h-index 73
Top works
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
- The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers
- Somatic Mutations of the HER2 Kinase Domain in Lung Adenocarcinomas
- Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
- Presence ofEpidermal Growth Factor ReceptorGene T790M Mutation as a Minor Clone in Non–Small Cell Lung Cancer
- Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
- TheTP53 gene, tobacco exposure, and lung cancer
- Genetic Predictors of MEK Dependence in Non–Small Cell Lung Cancer
- Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.
- Detection ofEGFRGene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay
- PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
- Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer
- EGFRMutation and Response of Lung Cancer to Gefitinib
- Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
- Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.
- PD-160 The relationship between epidermal growth factor receptor (EGFR) mutations and clinicopathologic features in non-small cell lung cancers
- Updated overall survival results of WJTOG 3405, a randomized phase III trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer harboring mutations of the epidermal growth factor receptor (EGFR).
- CT Fluoroscopy-Guided Biopsy of 1,000 Pulmonary Lesions Performed With 20-Gauge Coaxial Cutting Needles
- DNA methylation profiles of lung tumors.